Launch of CBG and CBD petition

RNS Number : 3896P

Cellular Goods PLC

20 June 2022

 

Press release

20 June 2022

Cellular Goods PLC

('Cellular Goods' or 'the Company')

Launch of industry campaign to lift restrictions on advertising and marketing CBD and CBG online

Cellular Goods (LSE: CBX), a UK-based wellness company providing premium consumer products formulated with lab-produced cannabinoids, today announces the launch of an industry-backed petition, 'Stop the ban on advertisement of CBG and CBD products on social media and search engines', to encourage Google and Meta, as well as other leading technology and social media companies, to remove cannabigerol ("CBG") and cannabidiol ("CBD") from their list of prohibited content and allow brands to sell and advertise these products on their platforms.

Cellular Goods has launched the petition in partnership with seven leading companies, who together comprise 'The CBG and CBD Brands Coalition' ("the Coalition"). The companies in the Coalition are Chanelle McCoy Health, Apothem Labs, Clearly Brands, Voyager Life, Kloris, Daye and CiiTech.

The Coalition is calling on the public to sign the petition, to encourage Google and Meta to change their advertising and marketing policies. The petition is hosted on Change.org and is available here .

With over 4.6 billion people using social media, this blanket ban is limiting companies' ability to promote their CBG and CBD products to potential consumers (Source: Digiday, 2022). The ban is also strengthening misconceptions around CBG and CBD, and hampering the public's ability to access verified information about them, making it more difficult for consumers to make informed purchasing decisions and learn about their wellness benefits.

A growing body of scientific and anecdotal evidence has shown that CBD and CBG have a variety of wellness effects. For example, Cellular Goods' white paper, Cannabinoids for the Prevention of Aging', has shown that CBG has a host of antioxidant and anti-inflammatory properties that make it an ingredient with immense skincare potential, preventing visible signs of aging caused by UV-light exposure and inflammation.

Anna Chokina, Chief Executive of Cellular Goods, commented: "CBD and CBG are increasingly accepted by society as well as across multiple jurisdictions worldwide. Despite this, some leading technology and social media companies, such as Google and Meta, have implemented blanket bans for cannabinoid brands on their platforms. This anachronistic policy is limiting access to verified information about CBG and CBD, as well as affecting legitimate businesses and preventing the sector from reaching its full potential.

"Through this industry-backed petition we are inviting leading technology and social media companies to remove the blanket ban on the sale of CBG and CBD. Not only will this support the industry's growth, but it will also enable the industry to raise awareness so that more people can take advantage of their wellness benefits."

For further information please contact:

Cellular Goods
Anna Chokina Chief Executive Neil Thapar Investor Relations	via Tancredi [phone] [phone]
Tennyson Securities
Corporate Broker Peter Krens	[phone]
Novum Securities
Corporate Broker Colin Rowbury Jon Belliss	[phone]
Tancredi Intelligent Communication
Media Relations Helen Humphrey Gabriela Amaya Garcia Charlie Hobbs [e-mail]	[phone] [phone] [phone]

About Cellular Goods PLC:

Cellular Goods is a UK-based wellness company that provides premium products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid-powered wellness products. The initial focus is on three product verticals: Function Better, Feel Better and Look Better. These three verticals encompass Cellular Goods' premium CBG skincare and CBD ingestible and topical athletic recovery products, with the first products launched in December 2021 initially through the Company's website. The Company's shares are listed on the main market of the London Stock Exchange. www.cellular-goods.com

 

END

 

 

NRAGPUUAQUPPPPB